IL6 and cancer: By analogy with the low immunogenicity of ‘cold’ tumors (46), this IL-6-mediated immunosuppressive effect decreases the immunogenic potential of cancer cells, thereby reducing both patients’ responsiveness to ICIs and their susceptibility to irAEs (13).